BWX Technologies Already Builds Reactors for the Navy. Why Is It Still the Cheapest Nuclear Stock?

BWX Technologies (NYSE: BWXT) is the lowest-valued nuclear stock despite its monopoly in supplying nuclear reactors and fuel to the U.S. Navy. Its Q2 revenue rose 18% YoY to $901.6M, with EPS up 5% to $1.07. The company has an $8.6B backlog and raised its yearly revenue guidance to $3.8B. BWX also expanded into commercial markets, with Q2 commercial revenue up 72% YoY to $303M.

Original reporting
Published Sep 6, 2026, 1:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 6, 2026, 1:41 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
BWX Technologies Already Builds Reactors for the Navy. Why Is It Still the Cheapest Nuclear Stock? — source image
Decision brief

The 30-second read

$BWXTBullishHigh
01

Why it matters

The earnings beat and contract win provide a fresh catalyst for the stock, likely prompting buying interest.

02

Market read

Strong earnings and a $1.4B contract make BWXT a notable trade idea in the defense sector.

03

What to watch

Potential regulatory or supply chain constraints on HALEU production.

Relevance 8/10Novelty 8/10Timing: today

Background

BWX Technologies reports Q2 results and a major Navy contract, raising full-year guidance.

Company-level read

Ticker impact

$BWXTBullishHigh confidence
Context

Q2 earnings disclosed $901.6M revenue, $1.07 EPS and a $1.4B Navy contract plus raised full-year guidance.

Expected impact

Potential price increase on the back of new guidance and contract win.

Evidence & confidence

First disclosure of sizable contract and guidance raise; material scale and clear catalyst.

Market effects

Highlights defense and nuclear sector demand, may lift peers.

U.S. defense contractors could see increased interest.

Limited to U.S. defense and nuclear markets.

Counterpoint

Valuation already low; execution risk on commercial expansion could limit upside.

Key entities

  • BWX Technologies

    U.S. defense contractor supplying nuclear reactors and fuel to the Navy.

Related articles

$CCJMed

Jefferies Sees Cameco (CCJ) and BWXT as Winners in the Nuclear Boom

Jefferies initiated coverage of Cameco (CCJ) and BWXT (BWXT) with 'Buy' ratings, setting price targets of $138 and $181 respectively, citing strong long-term prospects in nuclear energy. CCJ, a major uranium producer, and BWXT, a nuclear reactor provider, are positioned to benefit from global and U.S. initiatives to expand nuclear capacity. Both companies face risks, including uranium price volatility for CCJ and execution challenges for BWXT.

$BWXTMed

Expansion of Commercial Operations in Focus for BWX Technologies (BWXT)

Wells Fargo upgraded BWX Technologies (BWXT) to Equal Weight, lowering its target price to $170. The company reported Q2 2026 revenue of $901.6M, up from $764M last year, with adjusted EPS of $1.07. BWXT raised its full-year revenue guidance to $3.8B and adjusted EPS guidance to $4.70-$4.80. The stock is down 11.89% year-to-date. Management highlighted growth in commercial operations, while analysts noted risks related to revenue mix and leverage.

$DRSMedAI 8/10

Q2 Earnings Highs And Lows: Leonardo DRS (NASDAQ:DRS) Vs The Rest Of The Defense Contractors Stocks

Parsons (PSN) reported flat Q2 revenue of $1.58B, missing estimates, and lowered full-year guidance, causing its stock to drop 26.3%. BWX (BWXT) reported $901.6M revenue, up 18%, meeting expectations and beating EBITDA guidance. RTX (RTX) reported $24.71B revenue, up 14.5%, beating expectations and raising EPS guidance. The stock is up 3.2% since reporting.

$CCJHigh

Jefferies Gives Cameco (CCJ) Stock a Buy Rating With $138 Price Target

Jefferies initiated coverage of Cameco (CCJ) with a Buy rating and $138 price target, citing its leadership in uranium supply and nuclear energy demand. Shares rose 3.4% on the news. Wellington Management disclosed a new 2.09M share position. Q2 earnings of $0.13 per share missed estimates. Analysts maintain a Moderate Buy consensus with a $145.68 average target.

$CEGHighAI 8/10

Decade Nuclear Power Deals. These 3 Stocks Supply That Power

Constellation Energy (CEG) secured 30% of its nuclear output in long-term contracts, BWXT's backlog surged 40% to $8.4B, and GE Vernova's backlog reached $176B. CEG, BWXT, and GEV operate in distinct segments of the nuclear power supply chain, with unique cash flow profiles. CEG's Q2 EPS was $2.55, and full-year guidance was raised to $11.50-$12.50. BWXT's Q2 revenue was $902M, up 18% YoY, and GE Vernova's Q2 bookings hit $24.2B, up 88% YoY.